VesiBeta S 25 Tablet ER

Overview VesiBeta S 25 Tablet ER

Extended-release VesiBeta S 25 tablets combine two active ingredients to manage overactive bladder symptoms. This medication alleviates urinary urgency, frequency, and incontinence. Always follow your physician's instructions regarding dosage and treatment duration. The tablets can be taken with or without food, ideally at the same time daily. Discontinuing treatment prematurely may exacerbate symptoms; complete the prescribed course for optimal results. Commonly reported side effects include elevated blood pressure, upper respiratory inflammation (affecting the nose and throat), urinary tract infections, and headaches. Report any persistent or bothersome side effects to your doctor immediately. Before starting treatment, disclose all other medications and any existing health conditions, including pregnancy or breastfeeding. Patients with liver or kidney impairment should exercise caution, requiring close medical monitoring as directed by their doctor.

Uses of VesiBeta S 25 Tablet ER

Bladder control problems

Major Benefits of VesiBeta S 25 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for VesiBeta S 25 Tablet ER. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. While you can take it with or without food, consistency is key—take it at the same time each day.

Common Side effects of VesiBeta S 25 Tablet ER:

• High blood pressure
• Nasopharyngitis (inflammation of the throat and nasal passages)
• Urinary tract infection
• Headache
• Dryness in mouth
• Constipation
• Increased heart rate
• Blurred vision

How to use VesiBeta S 25 Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for VesiBeta S 25 Tablet ER. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. This medication can be administered with or without food, however, consistency in timing is recommended.

How VesiBeta S 25 Tablet ER works:

VesiBeta S 25 Extended-Release tablets contain Mirabegron and Solifenacin, which act synergistically to manage urinary symptoms. Mirabegron, a beta-3 adrenergic agonist, promotes bladder muscle relaxation by stimulating specific receptors. Solifenacin, an antimuscarinic agent, achieves a similar effect through a different mechanism. This dual action reduces the frequency, urgency, and incontinence associated with overactive bladder.

What if you forget to take VesiBeta S 25 Tablet ER :

NA